Title: Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
Journal: Journal of medicinal chemistry 20140911
Title: 1-(Arylsulfonyl)-2,3-dihydro-1H-quinolin-4-one derivatives as 5-HT(6) serotonin receptor ligands.
Journal: Bioorganic & medicinal chemistry letters 20110115
Title: 5-HT6 antagonism attenuates cue-induced relapse to cocaine seeking without affecting cocaine reinforcement.
Journal: The international journal of neuropsychopharmacology 20100801
Title: Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands.
Journal: Bioorganic & medicinal chemistry letters 20090615
Title: Indene-based scaffolds. 2. An indole-indene switch: discovery of novel indenylsulfonamides as 5-HT6 serotonin receptor agonists.
Journal: Journal of medicinal chemistry 20090212
Title: Impact of regional 5-HT depletion on the cognitive enhancing effects of a typical 5-ht(6) receptor antagonist, Ro 04-6790, in the Novel Object Discrimination task.
Journal: Psychopharmacology 20090101
Title: The selective 5-HT(6) receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801.
Journal: Behavioural brain research 20080409
Title: Discovery of 3-aryl-3-methyl-1H-quinoline-2,4-diones as a new class of selective 5-HT6 receptor antagonists.
Journal: Bioorganic & medicinal chemistry letters 20080115
Title: A three-dimensional pharmacophore model for 5-hydroxytryptamine6 (5-HT6) receptor antagonists.
Journal: Journal of medicinal chemistry 20050630
Title: Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
Journal: Journal of medicinal chemistry 20050324
Title: 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation--an effect sensitive to NMDA receptor antagonism.
Journal: Neuropharmacology 20040801
Title: Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790.
Journal: Psychopharmacology 20031201
Title: Identification of a potent and selective 5-HT(6) antagonist: one-step synthesis of (E)-3-(benzenesulfonyl)-2- (methylsulfanyl)pyrido[1,2-a]pyrimidin-4-ylidenamine from 2-(benzenesulfonyl)-3,3-bis(methylsulfanyl)acrylonitrile.
Journal: Journal of medicinal chemistry 20031106
Title: An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning.
Journal: The Journal of pharmacology and experimental therapeutics 20031101
Title: Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Journal: Journal of medicinal chemistry 20030703
Title: Effect of the 5-HT6 receptor antagonists Ro04-6790 and Ro65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine.
Journal: Pharmacology, biochemistry, and behavior 20030501
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry 20020419
Title: DARPP-32 mediates serotonergic neurotransmission in the forebrain.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20020305
Title: A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.
Journal: Neuropharmacology 20010801
Title: 5-HT(6) receptor antagonists: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides.
Journal: European journal of medicinal chemistry 20010201
Title: Effects of the 5-HT(6) receptor antagonist Ro 04-6790 on learning consolidation.
Journal: Behavioural brain research 20010108
Title: 5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist.
Journal: Journal of medicinal chemistry 19990128
Title: Involvement of 5-HT6 receptors in nigro-striatal function in rodents.
Journal: British journal of pharmacology 19981201
Title: The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum.
Journal: Molecular pharmacology 19980901
Title: Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors.
Journal: British journal of pharmacology 19980601
Title: A J Sleight, et al. Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors. Br J Pharmacol. 1998 Jun;124(3):556-62.
Title: Sudabeh Shirazi-Southall, et al. Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology. 2002 May;26(5):583-94.
